PATENT CLAIM ANALYSIS

Application Number: 15937564
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "312000"]

Abstract:
Modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), their pharmaceutical compositions, and methods of treating cystic fibrosis in patients with residual function mutations.

Claim (Index 7):
The method according to  claim 1 , comprising administering a pharmaceutical composition of Compound I or a pharmaceutically acceptable salt thereof concurrently with, prior to, or subsequent to a pharmaceutical composition comprising Compound II or II-d or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 90.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15125827', '13439379', '15747290', '14877914', '12909789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7834128697792173
- 35 USC 102 Novelty (BERT): 0.5200603679728627
- Combined Prediction Score: 0.7570776195985818
- Mean Citation Score: 311.545706
- Max Citation Score: 321.45975
- Similarity Product: 217.6412562803328

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test